niacinamide has been researched along with Charcot-Marie-Tooth Disease in 1 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Charcot-Marie-Tooth Disease: A hereditary motor and sensory neuropathy transmitted most often as an autosomal dominant trait and characterized by progressive distal wasting and loss of reflexes in the muscles of the legs (and occasionally involving the arms). Onset is usually in the second to fourth decade of life. This condition has been divided into two subtypes, hereditary motor and sensory neuropathy (HMSN) types I and II. HMSN I is associated with abnormal nerve conduction velocities and nerve hypertrophy, features not seen in HMSN II. (Adams et al., Principles of Neurology, 6th ed, p1343)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Meyer zu Horste, G | 1 |
| Miesbach, TA | 1 |
| Muller, JI | 1 |
| Fledrich, R | 1 |
| Stassart, RM | 1 |
| Kieseier, BC | 1 |
| Coleman, MP | 1 |
| Sereda, MW | 1 |
1 other study available for niacinamide and Charcot-Marie-Tooth Disease
| Article | Year |
|---|---|
The Wlds transgene reduces axon loss in a Charcot-Marie-Tooth disease 1A rat model and nicotinamide delays post-traumatic axonal degeneration.
Topics: Animals; Axons; Charcot-Marie-Tooth Disease; Disease Models, Animal; Female; Nerve Tissue Proteins; | 2011 |